Myeloid Differentiation Factor-88/Interleukin-1 Signaling Controls Cardiac Fibrosis and Heart Failure Progression in Inflammatory Dilated Cardiomyopathy
Authors:
- Przemyslaw BlyszczukPBPrzemyslaw Blyszczuk
- Gabriela KaniaGKGabriela Kania
- Thomas DieterleTDThomas Dieterle
- Rene R. MartyRMRene R. Marty
- Alan ValapertiAVAlan Valaperti
- Corinne BerthonnecheCBCorinne Berthonneche
- Thierry PedrazziniTPThierry Pedrazzini
- Christoph T. BergerCBChristoph T. Berger
- Stephan DirnhoferSDStephan Dirnhofer
- Christian M. MatterCMChristian M. Matter
- Josef M. PenningerJPJosef M. Penninger
- Thomas F. LüsCherTLThomas F. LüsCher
- 23 October 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 105 (9) , 912-920
Abstract
Rationale : The myeloid differentiation factor (MyD)88/interleukin (IL)-1 axis activates self–antigen-presenting cells and promotes autoreactive CD4 + T-cell expansion in experimental autoimmune myocarditis, a mouse model of inflammatory heart disease. Objective : The aim of this study was to determine the role of MyD88 and IL-1 in the progression of acute myocarditis to an end-stage heart failure. Methods and Results : Using α-myosin heavy chain peptide (MyHC-α)–loaded, activated dendritic cells, we induced myocarditis in wild-type and MyD88 −/− mice with similar distributions of heart-infiltrating cell subsets and comparable CD4 + T-cell responses. Injection of complete Freund’s adjuvant (CFA) or MyHC-α/CFA into diseased mice promoted cardiac fibrosis, induced ventricular dilation, and impaired heart function in wild-type but not in MyD88 −/− mice. Experiments with chimeric mice confirmed the bone marrow origin of the fibroblasts replacing inflammatory infiltrates and showed that MyD88 and IL-1 receptor type I signaling on bone marrow–derived cells was critical for development of cardiac fibrosis during progression to heart failure. Conclusions : Our findings indicate a critical role of MyD88/IL-1 signaling in the bone marrow compartment in postinflammatory cardiac fibrosis and heart failure and point to novel therapeutic strategies against inflammatory cardiomyopathy.Keywords
This publication has 39 references indexed in Scilit:
- MyD88-dependent, superoxide-initiated inflammation is necessary for flow-mediated inward remodeling of conduit arteriesJournal of Experimental Medicine, 2008
- Sex Differences in Autoimmune Disease from a Pathological PerspectiveThe American Journal of Pathology, 2008
- Prominin-1+/CD133+ bone marrow-derived heart-resident cells suppress experimental autoimmune myocarditisCardiovascular Research, 2008
- Interleukin-1 Receptor Type I Signaling Critically Regulates Infarct Healing and Cardiac RemodelingThe American Journal of Pathology, 2008
- Interleukin-13 Protects Against Experimental Autoimmune Myocarditis by Regulating Macrophage DifferentiationThe American Journal of Pathology, 2008
- Cardiac Troponin I but Not Cardiac Troponin T Induces Severe Autoimmune Inflammation in the MyocardiumCirculation, 2006
- Dendritic cells and autoimmune heart failureInternational Journal of Cardiology, 2006
- Inhibition of Urokinase-Type Plasminogen Activator or Matrix Metalloproteinases Prevents Cardiac Injury and Dysfunction During Viral MyocarditisCirculation, 2006
- MyD88 Signaling Controls Autoimmune Myocarditis InductionCirculation, 2006
- Effect of Hydrodynamics-Based Gene Delivery of Plasmid DNA Encoding Interleukin-1 Receptor Antagonist-Ig for Treatment of Rat Autoimmune MyocarditisCirculation, 2005